サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1195397

多汗症治療の世界市場：動向、予測、競合分析

Hyperhidrosis Treatment Report: Trends, Forecast and Competitive Analysis
出版日: | 発行: Lucintel | ページ情報: 英文 150 Pages | 納期: 3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円

ご注意:　DRM (デジタル著作権管理システム) 付PDFになります。
制限内容は、上記ライセンスの[詳細]アイコンをクリックしてご確認ください。

多汗症治療の世界市場：動向、予測、競合分析
出版日: 2022年11月01日
発行: Lucintel
ページ情報: 英文 150 Pages
納期: 3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

世界の多汗症治療の市場規模は、2023年から2028年にかけてCAGRで4%から6%の成長が予測されています。世界の多汗症治療市場の将来は、病院や外来手術センター市場での機会が見込まれています。また、この市場の主な促進要因は、個人のうつ病や不安の有病率の増加、人口の増加、および高度で効率的な治療の台頭が挙げられます。

当レポートでは、世界の多汗症治療市場について調査分析し、市場力学、セグメント別・地域別の市場動向と予測分析、競合分析、企業プロファイルなどの情報を提供しています。

目次

第1章 エグゼクティブサマリー

第2章 世界の多汗症治療市場：市場力学

  • イントロダクション、背景、分類
  • サプライチェーン
  • 業界の促進要因と課題

第3章 市場動向と予測分析（2017年～2028年）

  • マクロ経済の動向（2017年～2022年）と予測（2023年～2028年）
  • 世界の多汗症治療市場の動向（2017年～2022年）と予測（2023年～2028年）
  • 世界の多汗症治療市場：治療タイプ別
    • ボツリヌス毒素A
    • イオントフォレーシス
    • 外科的治療
    • 局所治療
    • 汗腺の非外科的マイクロ波エネルギー破壊
    • その他
  • 世界の多汗症治療市場：多汗症タイプ別
    • 腋窩多汗症
    • 手掌多汗症
    • 足底多汗症
    • その他
  • 世界の多汗症治療市場：流通チャネル別
    • 病院薬局
    • 小売薬局
    • オンライン薬局
  • 世界の多汗症治療市場：エンドユーザー別
    • 病院
    • 外来手術センター
    • その他（皮膚科クリニック・化粧品センター）

第4章 市場動向と予測分析：地域別（2017年～2028年）

  • 世界の多汗症治療市場：地域別
  • 北米
    • 治療タイプ別
    • 多汗症タイプ別
  • 欧州
    • 治療タイプ別
    • 多汗症タイプ別
  • アジア太平洋
    • 治療タイプ別
    • 多汗症タイプ別
  • その他の地域
    • 治療タイプ別
    • 多汗症タイプ別

第5章 競合の分析

  • 製品ポートフォリオ分析
  • 業務統合
  • ポーターのファイブフォース分析

第6章 成長機会と戦略分析

  • 成長機会分析
    • 治療タイプ別
    • 多汗症タイプ別
    • 流通チャネル別
    • エンドユーザー別
    • 地域別
  • 世界市場の新興動向
  • 戦略分析
    • 新製品の開発
    • 生産能力拡大
    • 合併、買収、合弁事業
    • 認定とライセンシング

第7章 主要企業プロファイル

  • Brickell Biotech Inc.
  • Allergan PLC.
  • Cynosure
  • Dermira Inc
  • Dermadry Laboratories Inc
  • GlaxoSmithKline PLC
  • Sesderma
  • Miramar Labs Inc
  • Ulthera Inc .
目次

Hyperhidrosis Treatment Market Trends and Forecast

The future of the global hyperhidrosis treatment market looks promising with opportunities in the hospitals and ambulatory surgical center market. The global hyperhidrosis treatment market is expected to grow with a CAGR of 4% to 6% from 2023 to 2028. The major drivers for this market are growing prevalence of depression and anxiety among individuals, increasing population, and rising advanced and efficient treatment.

Hyperhidrosis Treatment Market

A more than 150-page report is developed to help in your business decisions.  Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global hyperhidrosis treatment market report.

Hyperhidrosis Treatment Market by Segments

Hyperhidrosis Treatment Market by Segment

The study includes a forecast for the global hyperhidrosis treatment market by treatment type, hyperhidrosis type, distribution channel, end use industry, and region as follows:

Hyperhidrosis Treatment Market by Treatment Type [Value ($B) Shipment Analysis from 2017 to 2028]:

Botulinum Toxin A

Iontophoresis

Surgical Treatments

Topical Treatments

Non-surgical Microwave Energy Destruction of Sweat Glands

Others

Hyperhidrosis Treatment Market by Hyperhidrosis Type [Value ($B) Shipment Analysis from 2017 to 2028]:

Axillary Hyperhidrosis

Palmar Hyperhidrosis

Plantar Hyperhidrosis

Others

Hyperhidrosis Treatment Market by Distribution Channel [Value ($B) Shipment Analysis from 2017 to 2028]:

Hospital pharmacies

Retail pharmacies

Online pharmacies

Hyperhidrosis Treatment Market by End Use Industry [Value ($B) Shipment Analysis from 2017 to 2028]:

Hospitals

Ambulatory Surgical Centers

Others (Dermatology Clinics and Cosmetic Centers)

Hyperhidrosis Treatment Market by Region [Value ($B) shipment analysis for 2017-2028]:

North America

Europe

Asia Pacific

The Rest of the World

List of Hyperhidrosis Treatment Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies hyperhidrosis treatment companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the hyperhidrosis treatment companies profiled in this report include. 

Brickell Biotech Inc.

Allergan PLC

Cynosure

Dermira Inc.

Dermadry Laboratories inc.

GlaxoSmithKline PLC

Sesderma

Miramar Labs Inc.

Ulthera Inc.

Hyperhidrosis Treatment Market Insights

Lucintel forecasts that Botulin Toxin A will remain the largest segment over the forecast period due to its increasing usage in the treatment of focal hyperhidrosis as it is a safe and effective treatment that lasts longer than topical treatments 

Hospitals will remain the largest end use segment and is also expected to witness the highest growth over the forecast period due to ease in offering of hyperhidrosis treatment in hospitals.

North America will remain the largest region due to increasing key players, growing research and development activities and healthcare advancements in the country.

Features of the Hyperhidrosis Treatment Market

Market Size Estimates: Hyperhidrosis treatment market size estimation in terms of value ($B)

Trend And Forecast Analysis: Market trends (2017-2022) and forecast (2023-2028) by various segments and regions.

Segmentation Analysis: Hyperhidrosis treatment market size by various segments, such as treatment type, hyperhidrosis type, distribution channel, end user and region ($B)

Regional Analysis: Hyperhidrosis treatment market breakdown by North America, Europe, Asia Pacific, and the Rest of the World.

Growth Opportunities: Analysis on growth opportunities in different by treatment type, hyperhidrosis type, distribution channel, end user, and region.

Strategic Analysis: This includes M&A, new product development, and competitive landscape for the hyperhidrosis treatment market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the hyperhidrosis treatment market size?

Answer: The global hyperhidrosis treatment market is expected to reach an estimated $xx billion by 2028.

Q2. What is the growth forecast for hyperhidrosis treatment market?

Answer: The global hyperhidrosis treatment market is expected to grow with a CAGR of 4% to 6% from 2023 to 2028.

Q3. What are the major drivers influencing the growth of the hyperhidrosis treatment market?

Answer: The major drivers for this market are growing prevalence of depression and anxiety among individuals, increasing population, and rising advanced and efficient treatment.

Q4. What are the major segments for hyperhidrosis treatment market?

Answer: The future of the global hyperhidrosis treatment market looks promising with opportunities in the hospitals, ambulatory surgical centers and other market.

Q5. Who are the key hyperhidrosis treatment companies?

Answer: Some of the key hyperhidrosis treatment companies are as follows:

Brickell Biotech Inc.

Allergan PLC

Cynosure

Dermira Inc.

Dermadry Laboratories inc.

GlaxoSmithKline PLC

Sesderma

Miramar Labs Inc.

Ulthera Inc.

Q6. Which hyperhidrosis treatment segment will be the largest in future?

Answer: Lucintel forecasts that botulin toxin A will remain the largest segment over the forecast period due to its increasing usage in the treatment of focal hyperhidrosis as it is a safe and effective treatment that lasts longer than topical treatments.

Q7. In hyperhidrosis treatment market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region due to increasing key players, growing research and development activities and healthcare advancements in the country.

Q8. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% Customization Without any Additional Cost.

This report answers following 11 key questions

  • Q1. What are some of the most promising, high-growth opportunities for the hyperhidrosis treatment market by treatment type (botulinum toxin a, iontophoresis, surgical treatments, topical treatments, non-surgical microwave energy destruction of sweat glands and others), hyperhidrosis type (axillary hyperhidrosis, palmar hyperhidrosis, plantar hyperhidrosis and others), distribution channel (hospital pharmacies, retail pharmacies and online pharmacies), end user (hospitals, ambulatory surgical centers, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q2. Which segments will grow at a faster pace and why?
  • Q3. Which region will grow at a faster pace and why?
  • Q4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q5. What are the business risks and competitive threats in this market?
  • Q6. What are the emerging trends in this market and the reasons behind them?
  • Q7. What are some of the changing demands of customers in the market?
  • Q8. What are the new developments in the market? Which companies are leading these developments?
  • Q9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents  

1. Executive Summary

2. Global Hyperhidrosis Treatment Market: Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges 

3. Market Trends and Forecast Analysis from 2017 to 2028

  • 3.1: Macroeconomic Trends (2017-2022) and Forecast (2023-2028)
  • 3.2: Global Hyperhidrosis Treatment Market Trends (2017-2022) and Forecast (2023-2028)
  • 3.3: Global Hyperhidrosis Treatment Market by Treatment Type 
    • 3.3.1: Botulinum Toxin A
    • 3.3.2: Iontophoresis
    • 3.3.3: Surgical Treatments
    • 3.3.4: Topical Treatments
    • 3.3.5: Non-surgical Microwave Energy Destruction of Sweat Glands
    • 3.3.6: Others
  • 3.4: Global Hyperhidrosis Treatment Market by Hyperhidrosis Type
    • 3.4.1: Axillary Hyperhidrosis
    • 3.4.2: Palmar Hyperhidrosis
    • 3.4.3: Plantar Hyperhidrosis
    • 3.4.4: Others
  • 3.5: Global Hyperhidrosis Treatment Market by Distribution Channel
    • 3.5.1: Hospital pharmacies
    • 3.5.2: Retail pharmacies
    • 3.5.3: Online pharmacies
  • 3.6: Global Hyperhidrosis Treatment Market by End User
    • 3.6.1: Hospitals
    • 3.6.2: Ambulatory Surgical Centers
    • 3.6.3: Others (Dermatology Clinics and Cosmetic Centers)

4. Market Trends and Forecast Analysis by Region from 2017 to 2028

  • 4.1: Global Hyperhidrosis Treatment Market by Region
  • 4.2: North American Hyperhidrosis Treatment Market
    • 4.2.1: North American Hyperhidrosis Treatment Market by Treatment Type: botulinum toxin a, iontophoresis, surgical treatments, topical treatments, non-surgical microwave energy destruction of sweat glands and others
    • 4.2.2: North American Hyperhidrosis Treatment Market by Hyperhidrosis Type: axillary hyperhidrosis, palmar hyperhidrosis, plantar hyperhidrosis and others
  • 4.3: European Hyperhidrosis Treatment Market
    • 4.3.1: European Hyperhidrosis Treatment Market by Treatment Type: botulinum toxin a, iontophoresis, surgical treatments, topical treatments, non-surgical microwave energy destruction of sweat glands and others
    • 4.3.2: European Hyperhidrosis Treatment Market by Hyperhidrosis Type: axillary hyperhidrosis, palmar hyperhidrosis, plantar hyperhidrosis and others
  • 4.4: APAC Hyperhidrosis Treatment Market 
    • 4.4.1: APAC Hyperhidrosis Treatment Market by Treatment Type: botulinum toxin a, iontophoresis, surgical treatments, topical treatments, non-surgical microwave energy destruction of sweat glands and others
    • 4.4.2: APAC Hyperhidrosis Treatment Market by Hyperhidrosis Type: axillary hyperhidrosis, palmar hyperhidrosis, plantar hyperhidrosis and others
  • 4.5: ROW Hyperhidrosis Treatment Market 
    • 4.5.1: ROW Hyperhidrosis Treatment Market by Treatment Type: botulinum toxin a, iontophoresis, surgical treatments, topical treatments, non-surgical microwave energy destruction of sweat glands and others
    • 4.5.2: ROW Hyperhidrosis Treatment Market by Hyperhidrosis Type: axillary hyperhidrosis, palmar hyperhidrosis, plantar hyperhidrosis and others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis 

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Hyperhidrosis Treatment Market by Treatment Type
    • 6.1.2: Growth Opportunities for the Global Hyperhidrosis Treatment Market by Hyperhidrosis Type
    • 6.1.3: Growth Opportunities for the Global Hyperhidrosis Treatment Market by Distribution Channel
    • 6.1.4: Growth Opportunities for the Global Hyperhidrosis Treatment Market by End User
    • 6.1.5: Growth Opportunities for the Global Hyperhidrosis Treatment Market by Region
  • 6.2: Emerging Trends in the Global Hyperhidrosis Treatment Market 
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Hyperhidrosis Treatment Market 
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Hyperhidrosis Treatment Market 
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Brickell Biotech Inc.
  • 7.2: Allergan PLC.
  • 7.3: Cynosure
  • 7.4: Dermira Inc
  • 7.5: Dermadry Laboratories Inc
  • 7.6: GlaxoSmithKline PLC
  • 7.7: Sesderma
  • 7.8: Miramar Labs Inc
  • 7.9: Ulthera Inc   .